Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States)

Cancer Causes and Control

Volumn 9, Issue 4, 1998, Pages 425-432

  Nomura, Abraham M Y ^a   Stemmermann, Grant N ^b   Lee, James ^c   Kolonel, Laurence N ^c   Chen, Tai C ^d   Turner, Adrian ^d   Holick, Michael F ^d  

^a KUAKINI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^c UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Prostate cancer; United states; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLITE; NORMAL HUMAN; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROSTATE CANCER; UNITED STATES; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM;

AGE DISTRIBUTION; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; HAWAII; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; ODDS RATIO; POPULATION SURVEILLANCE; PROSTATIC NEOPLASMS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; VITAMIN D;

EID: 0031719143     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008875819232     Document Type: Article

References (23)

1. Schwartz GG, Hulka BS. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis) Anticancer Res 1990; 10: 1307-11.
2. Corder EH, Guess HA, Hulka BS, et al. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomark Prev 1993; 2: 467-72.
3. Braun MM, Helzsouer KJ, Hollis BW, Comstock GW. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control 1995; 6: 235-9.
4. Corder EH, Friedman GD, Vogelman JH, Orentreich N. Seasonal variation in vitamin D, vitamin D-binding protein, and dehydroepiandrosterone: risk of prostate cancer in black and white men. Cancer Epidemiol Biomark Prev 1995; 4: 655-9.
5. Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomark Prev 1996; 5: 121-6.
6. 3. Cancer Res 1992; 52: 515-20.
7. 3 receptors and actions in human prostate cancer cell lines. Endocrinology 1993; 132: 1952-60.
8. 3 on primary cultures of human prostatic cells. Cancer Res 1994; 54: 805-10.
9. 3. Endocrinology 1995; 136: 20-6.
10. Schwartz GG, Oeler TA, Uskokovic MR, Bahnson RR. Human prostate cancer cells: inhibition of proliferation by vitamin D analogs. Anticancer Res 1994; 14: 1077-81.
11. Stamp TCB, Round JM. Seasonal changes in human plasma levels of 25-hydroxyvitamin D. Nature 1974; 247: 563-5.
12. Tjellesen L, Christiansen C. Vitamin D metabolites in normal subjects during one year. A longitudinal study. Scand J Clin Lab Invest 1983; 43: 85-9.
13. Patale AA, Halloran BF, Murphy MM, Morris RC. Oral intake of phosphorus can determine serum concentrations of 1,15-dihydroxyvitamin D by determining its production rate in humans. J Clin Invest 1986; 77: 7-12.
14. Reichel H, Koeffler HP, Norman AW. The role of vitamin D endocrine system in health and disease. N Engl J Med 1989; 320: 980-91.
15. Chen TC, Turner AK, Holick MF. Methods for the determination of the circulating concentration of 25-hydroxyvitamin D. J Nutr Biochem 1990; 1: 315-9.
16. Chen TC, Turner AK, Holick MF. A method for the determination of the circulating concentration of 1,25-dihydroxyvitamin D. J Nutr Biochem 1990; 1: 320-7.
17. Nussbaum SR, Zahradnik RJ, Lavigne JR, et al. Highly sensitive two-site immunometric assay of parathyrin and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987; 33: 1364-7.
18. Armitage P, Berry G. Statistical Methods in Medical Research, Oxford, UK: Blackwell Scientific Publications, 1987: 120-3.
19. Hosmer DW, Lemeshow C. Applied Logistic Regression. New York, NY (USA): John Wiley & Sons, 1989: 190-7.
20. Tukey J. Exploratory Data Analysis. New York, NY (USA): Addison-Wesley, 1977: 100.
21. Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA. Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 1996; 56: 4108-10.
22. Ingles SA, Ross RK, Yu MC, et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997; 89: 166-70.
23. Feldman D. Androgen and vitamin D receptor gene polymorphisms: the long and short of prostate cancer risk. J Natl Cancer Inst 1997; 89: 109-11.